Clinical trial
Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After…
NCT00209352 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00209352 |
|---|---|
| Title | Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant |
| Official title | Randomized Trial of Long-Term Oral Acyclovir Usage to Prevent Varicella Zoster Virus Infection After Allogeneic Bone Marrow Transplant |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | Burroughs Wellcome Industry National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | VZV Infection After Bone Marrow Transplantation |
| Intervention type | Drug |
| Interventions | Acyclovir |
| Enrollment | 120 |
| Start date | Jun 1, 1985 |
| Completion | Jul 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 21, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: